Approaches for the Discovery of Drug Targets, Resistance Mechanisms and Biomarkers: An Overview of Cellecta Technologies
Paul Diehl, PhD
Monday, November 21, 2022
Tweet
Transcript
Embed
Email
Bookmark
<<
<
>
>>
Tweet
Facebook
Email
Chapters
Introduction
About Cellecta, Inc
Company Focus
Products and Platforms
CRISPR and RNAi Genetic Screens
Identify Genes Modulating Drug Responses
Sensitizer and Enhancer Knockouts
CRISPRi and CRISPRa Variations
CRISPR Human Genome-Wide Knock Out Library
Off-Shelf CRISPRa/CRISPRi Libraries
Custom Libraries
CRISPR-Test Assay Kits
CloneTracker™ Barcode Libraries
Analysis of Clonal Tumorigenic Populations
CloneTracker Barcode Libraries
DriverMap™ Expression Profiling
DriverMap Workflow: Single-Tube Profiling
Deeper Sequencing with Less Reads
DriverMap Profiling of Labor-Linked Gene Signatures in Blood
DriverMap™ Technology: Targeted Multiplex RT-PCR
No transcript for this webinar
More Information
Request info